Screener
Tarsus Pharmaceuticals, Inc. TARS Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:25 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001819790-26-000064
FAQ
- What is Tarsus Pharmaceuticals, Inc.'s operating lease ROU assets?
- Tarsus Pharmaceuticals, Inc. (TARS) reported operating lease ROU assets of 11.4% in Q2 2026.
- How has Tarsus Pharmaceuticals, Inc.'s operating lease ROU assets changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s operating lease ROU assets increased by 3.6% year-over-year, from 11% to 11.4%.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s operating lease ROU assets has grown at a 2.7% compound annual growth rate (CAGR), from 10% to 11.4%.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Tarsus Pharmaceuticals, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude